Company Hemostemix Inc Toronto S.E.
Equities
CA4236941080
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Christina Wu
DFI | Director of Finance/CFO | - | 20-03-04 |
Peter Pavlin
COO | Chief Operating Officer | - | 22-05-18 |
Fraser Henderson
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-13 |
Cameron Cole
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Lacey
CHM | Chairman | 67 | 20-03-10 |
Ronnie Hershmann
BRD | Director/Board Member | - | 20-02-08 |
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Loran Swanberg
BRD | Director/Board Member | - | 20-04-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 87,122,318 | 76,495,316 ( 87.80 %) | 0 | 87.80 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |